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Background: Preterm birth (PTB) (<37weeks) complicates approximately 15 million deliveries annually, 60%
occurring in low- and middle-income countries (LMICs). Several maternal morbidities increase the risk of
spontaneous (spPTB) and provider-initiated (piPTB) preterm birth, but there is little data from LMICs.
Method: We used the WHO Global Survey to analyze data from 172,461 singleton deliveries in 145 facilities across
22 LMICs. PTB and six maternal morbidities (height <145 cm, malaria, HIV/AIDS, pyelonephritis/UTI, diabetes and
pre-eclampsia) were investigated. We described associated characteristics and developed multilevel models for the
risk of spPTB/piPTB associated with maternal morbidities. Adverse perinatal outcomes (Apgar <7 at 5 minutes, NICU
admission, stillbirth, early neonatal death and low birthweight) were determined.
Results: 8.2% of deliveries were PTB; one-quarter of these were piPTB. 14.2% of piPTBs were not medically
indicated. Maternal height <145 cm (AOR 1.30, 95% CI 1.10–1.52), pyelonephritis/UTI (AOR 1.16, 95% CI 1.01–1.33),
pre-gestational diabetes (AOR 1.41, 95% CI 1.09–1.82) and pre-eclampsia (AOR 1.25, 95% CI 1.05–1.49) increased
odds of spPTB, as did malaria in Africa (AOR 1.67, 95%CI 1.32-2.11) but not HIV/AIDS (AOR 1.17, 95% CI 0.79-1.73).
Odds of piPTB were higher with maternal height <145 cm (AOR 1.47, 95% CI 1.23-1.77), pre-gestational diabetes
(AOR 2.51, 95% CI 1.81-3.47) and pre-eclampsia (AOR 8.17, 95% CI 6.80-9.83).
Conclusions: Maternal height <145 cm, diabetes and pre-eclampsia significantly increased odds of spPTB and
piPTB, while pyelonephritis/UTI and malaria increased odds of spPTB only. Strategies to reduce PTB and associated
newborn morbidity/mortality in LMICs must prioritize antenatal screening/treatment of these common conditions
and reducing non-medically indicated piPTBs where appropriate.
Keywords: Maternal, Newborn, Morbidity, Spontaneous preterm birth, Provider-initiated preterm birth, Maternal
height, Urinary tract infection, Pre-eclampsia, Diabetes, Malaria, HIVBackground
Preterm birth (birth before 37 weeks gestation) compli-
cates an estimated 15 million deliveries every year, of
which 1.1 million infants will die due to preterm birth-
related complications [1]. It is the leading cause of death
in the first month of life and preterm neonates are at an* Correspondence: vogeljo@who.int
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reproduction in any medium, provided the orincreased risk for post-neonatal mortality and a wide
range of respiratory, infectious, metabolic and nervous
system morbidities [2,3]. These risks persist beyond the
neonatal period – preterm birth is the second leading
cause of death in children under 5 [4] and preterm in-
fants have more illnesses, hospital admissions and edu-
cational and behavioral problems in childhood and early
adulthood [5-8]. They are also at greater risk of adult
chronic diseases, such as hypertension and diabetes [9]. In
2012, the “Born Too Soon: the Global Action Report on
Preterm Birth” was released, reporting the first country-
level estimates of preterm deliveries and mapping a com-
prehensive global strategy to address preterm birth [10].td. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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income countries (LMICs) and the incidence has con-
sistently risen in most countries [1,10]. A worldwide
co-operative effort to empower women and improve
the availability of family planning and pre-pregnancy
and antenatal care may prevent preterm birth, while up-
scaling simple, low-cost interventions can save the lives of
premature infants [10].
Approximately 45-50% of preterm deliveries follow
spontaneous onset of labour, 30% follow preterm rupture
of membranes and 15-20% of preterm births are provider-
initiated [11]. While the etiology of spontaneous preterm
birth is heterogeneous and poorly understood, many ma-
ternal factors are known to increase risk, such as age (ado-
lescence and advanced age), race, multiple pregnancy,
short inter-pregnancy interval, infections, medical condi-
tions, poor nutrition, lifestyle factors, psychological factors
and genetic predisposition [12-14]. Provider-initiated pre-
term birth can be life-saving for both mother and fetus,
such as in severe pre-eclampsia, placental abruption or
fetal distress. However, some provider-initiated preterm
deliveries may not have a strong medical indication or are
unintentionally preterm due to gestational age error [10].
Consequently, a significant fraction of the worldwide pre-
term birth burden may be unnecessary and avoidable.
There is a dearth of large-scale prevalence data from
LMICs on the different phenotypes of preterm birth (spon-
taneous and provider-initiated) and on antenatal maternal
morbidities known to contribute to preterm birth, as well
as neonatal morbidity and mortality amongst preterm in-
fants. In many resource-constrained settings, conditions
that are known to be risk factors for preterm birth (such
as urinary tract infections, malaria, undernutrition and
hypertensive disorders) are frequently under-diagnosed,
under-treated or both. Consequently, the magnitude of
the association between maternal morbidities, the risk
of preterm birth and neonatal morbidity and mortality
in these settings is difficult to establish, despite the avai-
lability of proven interventions for these conditions [10].
The Child Health Epidemiology Research Group
(CHERG) has conducted a series of analyses exploring
the association between maternal risk factors (nutri-
tion, infections and pregnancy morbidity) and intra-
uterine growth restriction and preterm birth [3]. As
part of that work, we conducted a secondary analysis
of facility deliveries in an international WHO dataset
to describe the prevalences and relationships between
selected maternal morbidities, spontaneous and provider-
initiated preterm birth and neonatal morbidity and mortal-
ity in preterm infants in 22 LMICs.
Methods
The WHO Global Survey on Maternal and Perinatal
Health (hereafter referred to as WHOGS) is a multi-country, facility-based, cross-sectional survey of maternal
and perinatal outcomes following delivery. The methodo-
logical details have been previously published [15,16]. In
brief, a stratified, multistage sampling design was used to
obtain a global sample of countries and health institutions.
Countries in WHO regions were grouped according to
adult and child mortality and countries were randomly
selected (probability proportional to population). Of
these, 24 participated in Africa (Angola, Democratic Re-
public of Congo, Algeria, Kenya, Niger, Nigeria and
Uganda), Latin America (Argentina, Brazil, Cuba, Ecuador,
Mexico, Nicaragua, Paraguay and Peru) and Asia
(Cambodia, China, India, Japan, Nepal, Philippines, Sri
Lanka, Thailand and Vietnam). From within the capital
city and two randomly selected provinces, seven institu-
tions with over 1,000 births per year and the capacity to
perform caesarean sections (CS) were randomly selected.
The study was conducted over 2004-2005 (Africa and
Latin America) and 2007-2008 (Asia).
All women delivering over 20 weeks gestation in par-
ticipating institutions during a three-month study period
were included. Trained data collectors reviewed and ex-
tracted relevant data from medical records to complete
the individual data forms on mothers and neonates dur-
ing admission for delivery until discharge or day 7 post-
partum (whichever came first). Maternal or neonatal
morbidity or mortality occurring after discharge or day
7 postpartum was not captured. Maternal morbidities
available in the WHOGS dataset known to increase the
risk of preterm birth were selected as exposure vari-
ables, namely: maternal height (as a proxy for maternal
malnutrition), malaria, HIV/AIDS (evidence in the hos-
pital records of the woman being HIV positive or having
AIDS), pyelonephritis/UTI (history of infection during
the pregnancy or delivery), pre-gestational diabetes
(women who became pregnant and were known to have
diabetes that antedated pregnancy) and pre-eclampsia
(blood pressure of 140/90 or greater, or an increase of
30 mm Hg systolic or 15 mm Hg diastolic over baseline
values on at least two occasions six or more hours apart,
developing after 20 weeks plus proteinuria/albumin-
uria). These conditions were recorded as binary vari-
ables (yes/no), except for maternal height which we
stratified into four groups (<145 cm, 145 – 149.9 cm,
150 – 154.9 cm, > = 155 cm) There is no universal def-
inition for low maternal height, however 145 cm and
150 cm are common cutoffs used in anthropometry
studies in LMICs ([17-19] and we reported results for
all four height groups (> = 155 cm as reference group).
Women were not universally screened for these condi-
tions; they may have been diagnosed at any point during
pregnancy. Information on severity, method of diagno-
sis and management of these morbidities was not re-
corded in the WHOGS.
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term birth with three mutually exclusive groups, namely
1) spontaneous preterm birth (spPTB) defined as deliv-
eries occurring before 37 weeks gestation following
spontaneous onset of labour, 2) provider-initiated pre-
term birth (piPTB) defined as delivery before 37 weeks
gestation following induction of labour, or no labour and
3) term births (> = 37 weeks gestation, reference group).
Medically indicated piPTB were those with one or more
documented medical indications, while non-medically
indicated piPTB deliveries were recorded as elective or
by maternal request only. Those piPTB deliveries with
no documented indications (medical or otherwise) were
reported as unknown. Perinatal outcomes were: Apgar
score <7 at 5 minutes, admission to neonatal intensive
care unit (NICU), stillbirth (neonate showing no signs of
life at time of delivery), low birthweight (birthweight
<2500 g) and early neonatal mortality (ENM) by dis-
charge or day 7. Deaths occurring in the first week of life
after discharge (at home or during a postpartum re-
admission) were not captured.
The WHOGS captured 290,610 deliveries in 373 insti-
tutions across Africa, Latin America and Asia. For this
analysis, we used data on liveborn singletons only from
the 22 LMICs in the WHOGS dataset, as defined by the
Organization for Economic Cooperation and Develop-
ment (www.oecd.org) (Japan was excluded as it is classi-
fied as a high-income country). We excluded multiple
pregnancies on account of the differences in preterm
birth rates between singletons and multiples and contro-
versy surrounding the optimal timing of delivery for
multiple births [20,21]. The relationship between mater-
nal morbidities and multiple pregnancies may also differ,
potentially leading to over-estimates of effect. We ex-
cluded facilities that had less than 500 deliveries, and
those with implausible/unrepresentative data or evidence
of poor data capture (i.e.: a preterm birth rate of less
than 3% or greater than 40%, or a low birthweight rate
of less than 1%). Deliveries with a gestational age of 22
to 45 weeks were included, however deliveries with
missing gestational age were excluded, as were outlier
gestational age/birthweight combinations identified by
algorithms developed by Alexander et al.[22] As per
these criteria, 172,461 singleton live births from 22
countries available for analysis (Figure 1). All deliveries
in Angola were excluded as they did not meet the above
data quality criteria.
The prevalences of maternal and neonatal characteris-
tics were reported for spPTB, piPTB and term birth
groups. Missing values were reported, however they
were excluded from significance testing. Chi-square tests
and Student’s t-test tested significance for spPTB vs term
and piPTB vs term. We also reported the prevalence of
preterm birth groups and maternal morbidities at thecountry level. Global and regional multi-level logistic re-
gression models (using the GENLINMIXED procedure
in SPSS) were used to determine adjusted odds ratios of
spPTB and piPTB associated with the maternal morbid-
ities, while accounting for clustering of mothers within
facilities. Maternal age, education, marital status, parity,
antenatal care, multiple pregnancy and facility (as a ran-
dom effect) were included as confounders in the multi-
variate models. The frequency of HIV/AIDS and malaria
was extremely low in Latin America and Asia and were
thus excluded from these models and the global model.
Missing values were excluded from modelling. Perinatal
outcomes were reported by gestational age bands (<28,
28 to 31, 32 to 33, 34 - <37 and >37 weeks) and by pre-
term groups. Ethical clearance from all Ministries of
Health of participating countries, WHO Ethics Review
Committee and that of each health institution or sub-
region were obtained. All analyses were performed using
SPSS 20 [23].
Results
Of the 172,461 liveborn singletons in this analysis,
14,155 (8.2%) were preterm (Figure 1). Approximately
three-quarters of all preterm births were spontaneous
(spPTB) while one-quarter were provider-initiated pre-
term births (piPTB); this proportion varied by region
(Latin America 31.7%, Africa 11.8% and Asia 22.6%)
(Table 1, Figures 2, 3, 4, 5). Globally, 85.8% of the
provider-initiated preterm deliveries were medically indi-
cated (Latin America 91.1%, Africa 88.7% and Asia
80.1%).
Table 2 shows maternal and neonatal characteristics
and preterm birth risk factors across all included preg-
nancies. Women experiencing spPTB trended signifi-
cantly towards younger age, less education, less
antenatal care, lower maternal height, as well as higher
rates of malaria (2.1% vs 1.1%, p < 0.001) and pre-
eclampsia (3.5% vs 2.6%, p < 0.001) compared to women
with term deliveries (Table 2). Vaginal deliveries (79.7%
vs 72.0%, p < 0.001) were more common among spPTB.
Differences between piPTB and term deliveries were
similar, however rates of malaria were slightly lower
(0.5% vs 1.1%, p = 0.003), while pyelonephritis/UTI (8.2%
vs 7.1%, p = 0.013), diabetes (2.9% vs 0.8%, p < 0.001) and
pre-eclampsia (18.2% vs 2.6%, p < 0.001) were higher in
women with piPTB. Caesarean section (66.4% vs 28.0%,
p < 0.001) was significantly more common in piPTB.
Most (97%) of all deliveries occurred in urban or peri-
urban facilities, but piPTBs were more commonly in ter-
tiary facilities (64.6%) compared to spPTB (59.1%) and
term deliveries (54.7%).
At the country level (Table 3), the median singleton
preterm birth rate was 8.3% (interquartile range 6.7% to
9.7%). The median proportion of preterm deliveries due
Table 1 Prevalence of preterm birth groups, by region
Global Latin America Africa Asia
Number of facilities 122 54 27 64
Number of liveborn singleton deliveries 172,461 64,181 30,544 77,736
Term births (> = 37 weeks) 158,295 (91.8) 59,288 (92.4) 28,284 (92.6) 70,723 (91.0)
All preterm births (< 37 weeks) 14,166 (8.2) 4,893 (7.6) 2,260 (7.4) 7,013 (9.0)
Spontaneous preterm birth (spPTB)a 10,750 (75.9) 3,336 (68.2) 1,990 (88.1) 5,424 (77.3)
Provider-initiated preterm births (piPTB)a 3,404 (24.0) 1,550 (31.7) 266 (11.8) 1,588 (22.6)
Preterm birth, labour status unknowna 12 (0.1) 7 (0.1) 4 (0.2) 1 (0.0)
Medically indicated piPTBb 2,920 (85.8) 1,412 (91.1) 236 (88.7) 1,272 (80.1)
Not medically indicated piPTBb 333 (9.8) 79 (5.1) 7 (2.6) 247 (15.6)
Indication unknown, piPTBb 151 (4.4) 59 (3.8) 23 (8.6) 69 (4.3)
aDenominator is all preterm births.
bDenominator is all provider-initiated preterm births.
Figure 1 Study flowchart.
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Figure 2 Phenotypes of preterm birth, 22 low- and middle-income countries.
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The proportion of piPTB deliveries that did not have a
medical indication was generally less than 10% of all
piPTBs, however facilities in Sri Lanka (23.8%), China
(22.3%) and India (16.2%) had the highest proportion of
non-medically indicated piPTBs. Height <145 cm ranged
from 0.2% (Algeria) to 9.7% (Nepal). Malaria and HIV/
AIDS were largely confined to African countries, with
malaria ranging from 0.1% (Algeria) to 28.6% (Niger)
and HIV/AIDS ranging from 0.2% (Algeria) to 3.7%
(Uganda) in Africa. Pyelonephritis/UTI ranged from
0.0% (Cambodia) to 28.2% (Ecuador), diabetes rangedFigure 3 Phenotypes of preterm birth, Latin American countries.from 0.1% (Kenya, Ecuador, Nicaragua, Cambodia and
Nepal) to 2.7% (Sri Lanka) and pre-eclampsia ranged
from 0.4% (Sri Lanka) to 6.9% (Ecuador).
Table 4 shows the bivariate and multivariate risk factor
analysis for preterm birth by regions and globally. In the
pooled global analysis, all maternal morbidities (mater-
nal height <145 cm, 145-149.9 cm and 150-154.9 cm,
diabetes, pre-eclampsia, UTI/pyelonephritis) were signifi-
cantly associated with spPTB, however these associations
varied in magnitude and significance at the regional level.
Diabetes was significant in Latin America and Africa and
pre-eclampsia was significant in Africa and Asia. Maternal
Figure 4 Phenotypes of preterm birth, African countries.
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eclampsia were significantly associated with piPTB. In
Africa, malaria was significantly associated with spPTB
(AOR 1.67, 95% CI 1.32 – 2.11) while HIV/AIDS did not
reach significance for spPTB (AOR 1.17, 95% CI 0.79 –
1.73) or piPTB (AOR 1.09, 95% CI 0.86 – 1.40).
For both spPTB and piPTB groups, the prevalence of
all adverse neonatal outcomes decreased with increasing
gestational age (Figures 6 and 7). Rates of adverse out-
comes by gestational age bands were comparable be-
tween spPTB and piPTB neonates, however the rates of
early neonatal death before discharge/day 7 were con-
sistently higher in piPTB neonates.Figure 5 Phenotypes of preterm birth, Asian countries.Discussion
We used a dataset of 172,461 deliveries across 145 facil-
ities in 22 LMICs to examine the contribution of com-
mon maternal conditions to the risk of spPTB and
piPTB independently in LMICs, as well as the associated
perinatal outcomes. The accepted figure for provider-
initiated preterm deliveries is 15-20%, [11] however we
found a piPTB rate of 24.0%, likely reflecting the higher
rate of intervention in our facility-based sampling frame.
In sub-Saharan African countries where resources for
obstetric intervention are often very limited [24] the
non-medically indicated piPTB rate was lower (2.6%).
The Latin American piPTB rate (31.7%) is likely due to
Table 2 Global maternal and neonatal characteristics for spontaneous, provider-initiated preterm births and term










Total 10,750 3,404 158,295
Maternal age <0.001 <0.001
<18 679 (6.3) 111 (3.3) 6,677 (4.2)
18-35 9,295 (86.5) 2,820 (82.8) 139,333 (88.0)
>35 771 (7.2) 473 (13.9) 12,233 (7.7)
Missing 5 (0.0) 0 (0.0) 52 (0.0)
Years of education <0.001 0.107
0 1,168 (10.9) 191 (5.6) 8,684 (5.5)
1 to 4 764 (7.1) 163 (4.8) 8,457 (5.3)
5 to 9 4,419 (41.1) 1,252 (36.8) 60,726 (38.4)
> = 10 4,139 (38.5) 1,731 (50.9) 77,824 (49.2)
Missing 260 (2.4) 67 (2.0) 2,604 (1.6)
Married 9,425 (87.7) <0.001 3,053 (89.7) 0.708 141,701 (89.5)
Missing 16 (0.1) 5 (0.1) 186 (0.1)
Parity <0.001 0.517
Parity 0 4,950 (46.0) 1,476 (43.4) 70,192 (44.3)
Parity 1-2 4,421 (41.1) 1,530 (44.9) 6,999 (44.2)
Parity > = 3 1,352 (12.6) 394 (11.6) 17,912 (11.3)
Missing 27 (0.3) 4 (0.1) 192 (0.1)
Number of antenatal care
visits
<0.001 <0.001
0 1,023 (9.5) 226 (6.6) 6,425 (4.1)
1 to 3 3,691 (34.3) 717 (21.1) 33,780 (21.3)
4 or more 5,804 (54.0) 2,396 (70.4) 115,685 (73.1)
Missing 232 (2.2) 65 (1.9) 2,405 (1.5)
Maternal height <0.001 <0.001
<145 cm 446 (4.1) 141 (4.1) 4,355 (2.8)
145 – 149.9 cm 991 (9.2) 332 (9.8) 12,583 (7.9)
150 – 154.9 cm 3,375 (31.4) 967 (28.4) 42,497 (26.8)
> = 155 cm 5,299 (49.3) 1,798 (52.8) 91,722 (58.0)
Missing 639 (5.9) 166 (4.9) 7,088 (4.5)
Antenatal medical and
obstetric conditions
Malaria 225 (2.1) <0.001 18 (0.5) 0.003 1,669 (1.1)
HIV 79 (0.7) 0.182 31 (0.9) 0.042 995 (0.6)
Pyelonephritis/UTI 712 (6.6) 0.065 279 (8.2) 0.013 11,228 (7.1)
Diabetes 91 (0.8) 0.442 100 (2.9) <0.001 1,233 (0.8)
Pre-eclampsia 380 (3.5) <0.001 619 (18.2) <0.001 4,047 (2.6)
Mode of delivery <0.001 <0.001
Vaginal delivery 8,571 (79.7) 1,144 (33.6) 114,010 (72.0)
Caesarean section 2,178 (20.3) 2,260 (66.4) 44,281 (28.0)
Missing 1 (0.0) 0 (0.0) 4 (0.0)
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Table 2 Global maternal and neonatal characteristics for spontaneous, provider-initiated preterm births and term
births in liveborn singletons (N = 172,449)* (Continued)
Neonates
Mean birth weight (SD) 2436.1 (630.5) <0.001c 2308.2 (659.8) <0.001 3154.4 (476.2)
Mean GA (SD) 34.4 (2.3) <0.001c 34.2 (2.4) <0.001 39.1 (1.2)
Female sex 5,181 (48.2) 0.240 1,623 (47.7) 0.197 77,225 (48.8)
Facility characteristics:
Location
Urban 9,746 (90.7) <0.001 3,269 (96.0) <0.001 14,887 (94.0)
Peri-urban 731 (6.8) 66 (1.9) 4,891 (3.1)
Rural 273 (2.5) 69 (2.0) 4,547 (2.9)
Level of facility
Primary 347 (3.2) <0.001 19 (0.6) <0.001 3,471 (2.2)
Secondary 3,261 (30.3) 938 (27.6) 56,444 (35.7)
Tertiary 6,355 (59.1) 2,199 (64.6) 86,577 (54.7)
Other referral level 787 (7.3) 248 (7.3) 11,803 (7.5)
*12 preterm deliveries with unknown labour status excluded from this table.
aP value calculated by comparison between spontaneous preterm birth and term births only.
bP value calculated by comparison between provider-initiated preterm birth and term births only.
cStudents t-test used to calculated p-values for continuous variables birthweight and gestational age.
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CS in these countries [25], however the rate of elective
piPTB deliveries in this region was also quite low (5.1%).
The most surprising finding was the non-medically indi-
cated piPTB rate in Asia accounting for over 15% of all
provider-initiated preterm deliveries, driven by facilities in
Sri Lanka, China and India. While the reason for this is
unclear, it could be due to gestational age estimation
errors, mis-documentation of indications for delivery, ma-
ternal demand for elective deliveries (despite being pre-
term) or a failure by providers to recognize the risks of
elective preterm deliveries. Elective deliveries should only
be performed when there is a high degree of confidence in
the gestational age estimate as they increase the risk of
some adverse maternal outcomes [26-28], and we have
shown that rates of neonatal morbidity and mortality at
34- < 37 weeks were considerably higher. In resource-
constrained settings, reducing these rates also allows
resource redirection to mothers in medical need of in-
tervention. Maternal characteristics associated with pre-
term deliveries were consistent with the literature [10,13]
however in several countries and morbidities, the ex-
tremely low prevalence is suggestive of significant under-
diagnosis and/or a lack of universal screening protocols.
There is a paucity of large-scale maternal morbidity pre-
valence data from LMICs, particularly for UTI’s, pre-
gestational diabetes and pre-eclampsia - our data, while
suggestive of consistent under-recognition of common
morbidities, are the largest and best available for several
LMICs.Others have reported on the increased risk of PTB
with low maternal height, ranging from OR 1.17 to 1.61
[29-31], however we have shown this occurs independ-
ently for spPTB and piPTB at <145 cm and 145-149.9 cm.
The association with spPTB was stronger in women in
Asia where the prevalence of maternal height <145 cm
was higher, while Latin America and Africa did not reach
significance – this could be due to the lower prevalence of
shorter women in these regions, malnutrition increasing
the risk of preterm birth [32] or potentially a racial predis-
position at play. The relationship with piPTB may be due
to the clinician’s desire to avoid obstructed labor associ-
ated with cephalopelvic disproportion [33].
Malaria can contribute to almost 25% of maternal deaths
in endemic settings [34] and intermittent treatment during
pregnancy has been shown to reduce preterm birth [35].
Malaria has been associated with 2-3 times the risk of pre-
term birth [36-39], supported by the 67% increase in odds
in our African data. With regards to HIV, a meta-analysis
of 31 studies by Brocklehurst and colleagues reported OR
1.83 (1.63 – 2.06) for preterm delivery associated with HIV
infection in pregnancy [40] while Lopez and colleagues
demonstrated increased odds for spPTB (AOR 2.1, 1.5 –
3.0) and piPTB (AOR 3.2, 1.8 - 5.7) [41]. Our failure to find
an association is likely related to the HIV rates in our data-
set being considerably lower than national data. This may
be due to under-detection, under-recognition or under-
documentation of HIV infection during delivery. Further-
more, universal HIV screening may not be in use in these
facilities, or mothers are declining testing or not reporting.
Table 3 Prevalence of preterm birth and maternal risk factors, by country
Africa Latin America
DR Congo Algeria Kenya Niger Nigeria Uganda Argentina Brazil Cuba Ecuador Mexico
Number of liveborn singleton deliveries 3,239 10,493 2,415 1,225 1,433 11,739 4,916 1,890 10,149 8,481 18,316
Number of facilities 4 10 2 2 2 7 5 2 9 5 16
N (%) N (%) N (%) N (%) N (%) N (%) N (%) N (%) N (%) N (%) N (%)
Term births (> = 37 weeks)a 2,829 (87.3) 10,013 (95.4) 2,253 (93.3) 1,110 (90.6) 1,312 (91.6) 10,767 (91.7) 4,432 (90.2) 1,689 (89.4) 9,650 (95.1) 7,895 (93.1) 16,857 (92.0)
All preterm births (<37 weeks)a 410 (12.7) 480 (4.6) 162 (6.7) 115 (9.4) 121 (8.4) 972 (8.3) 484 (9.8) 201 (10.6) 499 (4.9) 586 (6.9) 1,459 (8.0)
Spontaneous preterm birthb 378 (92.2) 374 (77.9) 153 (94.4) 100 (87.0) 109 (90.1) 876 (90.1) 294 (60.7) 162 (80.6) 257 (51.5) 522 (89.1) 1,019 (69.8)
Provider-initiated preterm birthb 32 (7.8) 106 (22.1) 9 (5.6) 15 (13.0) 12 (9.9) 92 (9.5) 187 (38.6) 39 (19.4) 242 (48.5) 64 (10.9) 439 (30.1)
Preterm birth, labour status unknownb 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 4 (0.4) 3 (0.6) 0 (0.0) 0 (0.0) 0 (0.0) 1 (0.0)
Medical indicated piPTBc 31 (96.9) 100 (94.3) 8 (88.9) 13 (86.7) 12 (100.0) 72 (78.3) 180 (96.3) 38 (97.4) 236 (97.5) 49 (76.6) 357 (81.3)
Not medically indicated piPTBc 1 (3.1) 1 (1.0) 0 (0.0) 1 (6.7) 0 (0.0) 4 (4.3) 6 (3.2) 1 (2.6) 0 (0.0) 7 (10.9) 48 (10.9)
Indication unknown, piPTBc 1 (3.1) 5 (4.7) 1 (11.1) 1 (6.7) 0 (0.0) 16 (17.4) 1 (0.5) 0 (0.0) 6 (2.5) 8 (12.5) 34 (7.7)
Maternal morbidities
Maternal heighta
<145 cm 22 (0.7) 17 (0.2) 24 (1.0) 5 (0.4) 120 (8.4) 154 (1.3) 48 (1.0) 15 (0.8) 110 (1.1) 355 (4.2) 401 (2.2)
145 - 149.9 cm 88 (2.7) 53 (0.5) 89 (3.7) 11 (0.9) 46 (3.2) 503 (4.3) 219 (4.5) 52 (2.8) 448 (4.4) 949 (11.2) 1,327 (7.2)
150 - 154.9 cm 407 (12.6) 693 (6.6) 271 (11.2) 56 (4.6) 255 (17.8) 1,832 (15.6) 848 (17.2) 218 (11.5) 1,686 (16.6) 2,548 (30.0) 4,867 (26.6)
> = 155 cm 2,669 (82.4) 9,686 (92.3) 1,209 (50.1) 1,153 (94.1) 805 (56.2) 8,271 (70.5) 3,141 (63.9) 758 (40.1) 7,905 (77.9) 4,152 (49.0) 10,612 (57.9)
Missing 53 (1.6) 44 (0.4) 822 (34.0) 0 (0.0) 207 (14.4) 979 (8.3) 660 (13.4) 847 (44.8) 0 (0.0) 477 (5.6) 1,109 (6.1)
Malariaa 413 (12.8) 13 (0.1) 10 (0.4) 350 (28.6) 207 (14.5) 854 (7.3) 0 (0.0) 0 (0.0) 4 (0.0) 0 (0.0) 10 (0.1)
HIV/AIDSa 43 (1.3) 19 (0.2) 16 (0.7) 3 (0.2) 12 (0.8) 415 (3.6) 39 (0.8) 21 (1.1) 49 (0.5) 28 (0.3) 80 (0.4)
Pyelonephritis/UTIa 234 (7.2) 267 (2.5) 65 (2.7) 34 (2.8) 1 (0.1) 912 (7.8) 216 (4.4) 243 (12.9) 487 (4.8) 2,390 (28.2) 3,715 (20.3)
Diabetesa 12 (0.4) 103 (1.0) 3 (0.1) 3 (0.2) 3 (0.2) 30 (0.3) 66 (1.3) 39 (2.1) 213 (2.1) 11 (0.1) 129 (0.7)


















Table 3 Prevalence of preterm birth and maternal risk factors, by country (Continued)
Latin America Asia
Nicaragua Paraguay Peru Cambodia China India Nepal Ph lippine Sri Lanka Thailand Vietnam
Number of liveborn singleton deliveries 5,002 2,624 12,803 5,064 8,740 17,199 7,440 ,971 14,037 8,926 7,439
Number of facilities 4 4 9 4 9 13 6 8 12 9 3
N (%) N (%) N (%) N (%) N (%) N (%) N (%) (%) N (%) N (%) N (%)
Term births (> = 37 weeks)a 4,669 (93.3) 2,367 (90.2) 11,729 (91.6) 4,733 (93.5) 8,247 (94.4) 14,554 (85.0) 6,764 (90.9) 8,2 0 (91.7) 13,069 (93.1) 7,977 (89.6) 7,129 (95.8)
All preterm births (<37 weeks)a 333 (6.7) 257 (9.8) 1,074 (8.4) 331 (6.5) 493 (5.6) 2,565 (15.0) 676 (9.1) 7 1 (8.3) 968 (6.9) 929 (10.4) 310 (4.2)
Spontaneous preterm birthb 239 (71.8) 161 (62.6) 682 (63.5) 281 (84.9) 314 (63.7) 2,091 (81.5) 592 (87.6) 6 (86.6) 481 (49.7) 760 (81.8) 263 (84.8)
Provider-initiated preterm birthb 94 (28.2) 93 (36.2) 392 (36.5) 50 (15.1) 179 (36.3) 474 (18.5) 84 (12.4) 9 (13.4) 487 (50.3) 168 (18.1) 47 (15.2)
Preterm birth, labour status unknownb 0 (0.0) 3 (1.2) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) (0.0) 0 (0.0) 1 (0.1) 0 (0.0)
Medical indicated piPTBc 83 (88.3) 84 (90.3) 385 (98.2) 49 (98.0) 131 (73.2) 390 (82.3) 82 (97.6) 9 (90.9) 334 (68.6) 151 (89.9) 45 (95.7)
Not medically indicated piPTBc 11 (11.7) 4 (4.3) 2 (0.5) 1 (2.0) 40 (22.3) 77 (16.2) 0 (0.0) (0.0) 116 (23.8) 11 (6.5) 2 (4.3)
Indication unknown, piPTBc 0 (0.0) 5 (5.4) 5 (1.3) 0 (0.0) 8 (4.5) 7 (1.5) 2 (2.4) (9.1) 37 (7.6) 6 (3.6) 0 (0.0)
Maternal morbidities
Maternal heighta
<145 cm 202 (4.0) 31 (1.2) 491 (3.8) 128 (2.5) 35 (0.4) 721 (4.2) 722 (9.7) 3 4 (4.3) 772 (5.5) 129 (1.4) 56 (0.8)
145 - 149.9 cm 635 (12.7) 81 (3.1) 1,505 (11.8) 527 (10.4) 122 (1.4) 1,842 (10.8) 1,575 (21.2) 7 2 (8.3) 2,024 (14.4) 727 (8.1) 341 (4.6)
150 - 154.9 cm 1,769 (35.4) 424 (16.2) 3,776 (29.5) 1,678 (33.1) 1,171 (13.4) 8,667 (50.6) 3,801 (51.1) 2,7 9 (30.3) 4,569 (32.5) 2,274 (25.5) 2,313 (31.1)
> = 155 cm 2,396 (47.9) 1,876 (71.5) 6,099 (47.6) 2,644 (52.2) 7,403 (84.7) 5,848 (34.2) 1,334 (17.9) 3,9 5 (43.9) 6,589 (46.9) 5,663 (63.4) 4,728 (63.6)
Missing 0 (0.0) 212 (8.1) 932 (7.3) 87 (1.7) 9 (0.1) 41 (0.2) 8 (0.1) 1,1 1 (13.3) 83 (0.6) 133 (1.5) 1 (0.0)
Malariaa 0 (0.0) 2 (0.1) 2 (0.0) 2 (0.0) 0 (0.0) 37 (0.2) 2 (0.0) (0.0) 2 (0.0) 3 (0.0) 1 (0.0)
HIV/AIDSa 20 (0.4) 3 (0.1) 36 (0.3) 42 (0.8) 17 (0.2) 57 (0.3) 7 (0.1) (0.2) 11 (0.1) 111 (1.2) 57 (0.8)
Pyelonephritis/UTIa 266 (5.3) 53 (2.0) 2,602 (20.3) 2 (0.0) 6 (0.1) 84 (0.5) 5 (0.1) 4 9 (5.6) 86 (0.6) 15 (0.2) 37 (0.5)
Diabetesa 6 (0.1) 12 (0.5) 21 (0.2) 5 (0.1) 70 (0.8) 45 (0.3) 6 (0.1) (0.5) 385 (2.7) 199 (2.2) 14 (0.2)
Pre-eclampsiaa 135 (2.7) 87 (3.4) 830 (6.5) 108 (2.1) 184 (2.1) 567 (3.3) 88 (1.2) 3 3 (4.0) 54 (0.4) 188 (2.1) 75 (1.0)
aPercentage calculated using number of liveborn singleton deliveries in country X as denominator.
bPercentage calculated using number of all preterm births in country X as denominator.






































Table 4 Crude and adjusted odds of preterm birth (spontaneous and provider-initiated) associated with maternal
morbidities, by region and globally
Spontaneous preterm birth (spPTB) Provider-initiated preterm birth (piPTB)
OR (95% CI) AOR (95% CI) OR (95% CI) AOR (95% CI)
Latin America Maternal height
<145 cm 1.15 (0.92 – 1.42) 1.05 (0.85 – 1.28) 0.99 (0.72 – 1.36) 1.15 (0.85 – 1.57)
145 – 149.9 cm 1.08 (0.95 – 1.23) 1.06 (0.93 – 1.20) 0.92 (0.76 – 1.11) 0.99 (0.82 – 1.20)
150 – 154.9 cm 1.10 (1.01 – 1.19) 1.06 (0.96 – 1.17) 0.93 (0.82 – 1.05) 0.99 (0.86 – 1.13)
> = 155 cm Ref Ref Ref Ref
Pyelonephritis/UTI 1.07 (0.97 – 1.18) 1.20 (1.01 – 1.42)* 1.08 (0.94 – 1.23) 1.27 (0.96 – 1.67)
Diabetes 1.34 (0.93 – 1.92) 1.72 (1.15 – 2.58)* 3.47 (2.48 – 4.85) 2.23 (1.48 – 3.38)*
Pre-eclampsia 1.38 (1.18 – 1.62) 1.18 (0.92 – 1.53) 7.80 (6.90 – 8.83) 7.43 (5.69 – 9.69)
Africa Maternal height
<145 cm 2.02 (1.44 – 2.83) 1.46 (0.81 – 2.62) 1.91 (0.78 – 4.67) 1.21 (0.75 – 1.96)
145 – 149.9 cm 1.22 (0.93 – 1.62) 0.91 (0.72 – 1.16) 1.73 (0.94 – 3.19) 1.13 (0.80 – 1.58)
150 – 154.9 cm 1.51 (1.33 – 1.72) 1.22 (1.04 – 1.43)* 1.33 (0.93 – 1.89) 1.05 (0.92 – 1.19)
> = 155 cm Ref Ref Ref Ref
Malaria 2.00 (1.72 – 2.33) 1.67 (1.32 – 2.11)* 1.06 (0.64 – 1.76) 1.01 (0.84 – 1.21)
HIV/AIDS 1.10 (0.78 – 1.54) 1.17 (0.79 – 1.73) 1.61 (0.75 – 3.42) 1.09 (0.86 – 1.40)
Pyelonephritis/UTI 0.91 (0.73 – 1.13) 0.91 (0.66 – 1.24) 0.44 (0.20 – 0.99) 0.91 (0.81 – 1.02)
Diabetes 1.76 (1.06 – 2.92) 1.96 (1.03 – 3.71)* 4.71 (2.06 – 10.75) 1.66 (1.09 – 2.55)*
Pre-eclampsia 1.40 (1.02 – 1.93) 1.55 (1.11 – 2.17)* 13.57 (9.74 – 18.91) 3.59 (2.02 – 6.40)*
Asia Maternal height
<145 cm 2.12 (1.88 – 2.41) 1.39 (1.13 – 1.71)* 1.94 (1.56 – 2.41) 1.58 (1.26 – 1.98)*
145 – 149.9 cm 1.60 (1.46 – 1.76) 1.21 (1.08 – 1.36)* 1.48 (1.26 – 1.73) 1.25 (1.02 – 1.53)*
150 – 154.9 cm 1.54 (1.45 – 1.64) 1.13 (1.01 – 1.26)* 1.18 (1.05 – 1.32) 1.11 (0.97 – 1.27)
> = 155 cm Ref Ref Ref Ref
Pyelonephritis/UTI 1.53 (1.21 – 1.95) 1.17 (0.78 – 1.77) 1.25 (0.78 – 2.01) 1.30 (0.68 – 2.49)
Diabetes 0.82 (0.60 – 1.12) 1.15 (0.82 – 1.62) 3.83 (2.91 – 5.06) 2.58 (1.59 – 4.19)*
Pre-eclampsia 1.64 (1.39 – 1.94) 1.26 (1.00 – 1.59)* 7.69 (6.56 – 9.02) 8.34 (6.54 – 10.64)*
Global Maternal height
<145 cm 1.77 (1.60 – 1.96) 1.30 (1.10 – 1.52)* 1.65 (1.39 – 1.97) 1.47 (1.23 – 1.77)*
145 – 149.9 cm 1.36 (1.27 – 1.46) 1.15 (1.06 – 1.24)* 1.35 (1.20 – 1.52) 1.18 (1.02 – 1.36)*
150 – 154.9 cm 1.38 (1.32 – 1.44) 1.11 (1.04 – 1.19)* 1.16 (1.07 – 1.26) 1.08 (0.98 – 1.19)
> = 155 cm Ref Ref Ref Ref
Pyelonephritis/UTI 0.93 (0.86 – 1.01) 1.16 (1.01 – 1.33)* 1.17 (1.03 – 1.32) 1.24 (0.96 – 1.59)
Diabetes 1.09 (0.88 – 1.35) 1.41 (1.09 – 1.82)* 3.86 (3.14 – 4.74) 2.51 (1.81 – 3.47)*
Pre-eclampsia 1.40 (1.26 – 1.55) 1.25 (1.05 – 1.49)* 8.47 (7.72 – 9.29) 8.17 (6.80 – 9.83)*
*adjusted odds ratios that reached statistical significance (95% CI excludes 1).
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http://www.biomedcentral.com/1471-2393/14/56Regardless, under-diagnosis is a cause for concern in the
larger African facilities that participated in the WHOGS,
where obstetric services and HIV diagnostic capacity are
likely higher than average.
The increased risk of prematurity in mothers with pre-
gestational diabetes is nearly four-fold higher [42], how-
ever this is at least partly driven by iatrogenic prematurity
[43] - whether pre-gestational diabetes is an independentrisk factor for spPTB is unclear. Our findings support the
60% increase in the odds of spPTB reported by Sibai and
colleagues [44]. Given the growing global epidemic of dia-
betes and obesity, preterm birth rates will likely be
driven higher by this relationship. Our findings also
support studies that have implicated urinary tract infec-
tions [45] and pre-eclampsia [46,47] in preterm birth. Pre-
eclampsia is a leading indication for piPTB [46] - the lower
Figure 6 Perinatal outcomes in spontaneous preterm births.
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http://www.biomedcentral.com/1471-2393/14/56magnitude risk of piPTB in African countries (AOR 3.59)
compared to overall (AOR 8.17) likely reflects a rela-
tively lower number of women with pre-eclampsia being
managed with caesarean, or perhaps comparative overuse
in other settings. It is important to note that many of
these conditions can co-occur in LMICs, and improved
access and use of health prevention strategies (such as
antenatal screening programmes) in these settings will
likely yield a secondary benefit of reduced spPTB rates.
Although most adverse perinatal outcomes decreased in
prevalence with increasing gestational age, the NICU ad-
mission rate was generally lower than we expected, (par-
ticularly for early preterm infants) possibly due to poorFigure 7 Perinatal outcomes in provider-initiated preterm birth.NICU access. In an estimation exercise for CHERG,
Blencowe et al estimated that in countries with <80%
national facility delivery rates, <50% of infants had access
to a neonatal intensive care unit (personal communica-
tion). While piPTB may save an infant’s life, the higher
early neonatal mortality rate following piPTB likely re-
flects the maternal indication.
Our analysis had several strengths - it was conducted
in a large, multi-country dataset and stratified by type
of preterm birth and region. Most preterm analyses are
from high-income settings and are generally not segre-
gated by preterm phenotypes; they are unable to distin-
guish increased risks of of spPTB from an increased
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http://www.biomedcentral.com/1471-2393/14/56propensity of providers to intervene (such as for mater-
nal height <145 cm, diabetes and pre-eclampsia). These
epidemiological data on preterm birth groups and ma-
ternal morbidities are the best available for several
LMICs. Despite our efforts controlling for multiple con-
founders, some limitations persist. The sample was pri-
marily drawn from larger, urban facilities and therefore
subject to reporting and/or selection biases (higher rates
of complicated pregnancies, or wealthier and more urban
mothers attending tertiary care level facilities). Higher CS
rates in some countries and facilities reflect this, therefore
these findings are not representative of the population and
can only be extrapolated to similar settings. Furthermore,
the data is based on retrospective review of medical re-
cords (which may have been sub-optimal) and morbidity
surveillance may not have been universal in these facilities.
The method of diagnosis, timing, severity and treatment
of these morbidities, as well as the method of gestational
age determination, was not recorded. We lacked data on
some relevant PTB risk factors, such as smoking, birth
spacing, sexually transmitted infections, physical exertion
and lifestyle risk factors. Intrauterine fetal deaths were not
included. It is important to acknowledge that women who
undergo preterm birth and/or provider interventions may
be more likely to have a risk factor diagnosed than other
women, potentially distorting associations.
Conclusion
In facility deliveries in 22 low- and middle-income
countries, 24.0% of preterm births were provider-initiated,
yet nearly 10% of these were without a medical indication
and potentially avoidable. Maternal height <155 cm, py-
elonephritis/UTI, diabetes, pre-eclampsia and malaria in-
dependently increased the odds of spontaneous preterm
birth. Furthermore, malaria was significantly associated
with spontaneous preterm birth in Africa. Aside from ma-
ternal height, these common maternal conditions are
amenable to screening, prevention and treatment – failure
to do so increases the risk of preterm birth and associated
neonatal morbidity and mortality in LMICs. Strategies to
reduce preterm birth in LMICs must prioritise maternal
antenatal screening and treatment of these conditions.
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